3-溴-5-(三氟甲基)苯甲醛 | 477535-41-4

• 物质功能分类: 有机原料 - 醛类化合物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-溴-5-(三氟甲基)苯甲醛
• 中文别名: 3-溴-5-三氟甲基苯甲醛；3-三氟甲基-5-溴苯甲醛
• 英文名称: 3-bromo-5-(trifluoromethyl)benzaldehyde
• CAS: 477535-41-4
• 化学式: C₈H₄BrF₃O
• mdl: MFCD08059506
• 分子量: 253.018
• InChiKey: PCRLZGCXLNNMFL-UHFFFAOYSA-N

物化性质

• 沸点：
  219℃
• 密度：
  1.677
• 闪点：
  86℃
• 稳定性/保质期：

  按规定使用和贮存不会分解，避免接触氧化物。

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.125
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 危险品标志：
  Xi
• 海关编码：
  2913000090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335
• 储存条件：
  请将药品存放在密闭、阴凉、干燥的地方。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3-Bromo-5-trifluoromethylbenzaldehyde
Synonyms: 3-Bromo-5-(trifluoromethyl)benzaldehyde

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H302: Harmful if swallowed
H317: May cause an allergic skin reaction
H319: Causes serious eye irritation
P280: Wear protective gloves/protective clothing/eye protection/face protection
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing

---

Section 3. Composition/information on ingredients.
Ingredient name: 3-Bromo-5-trifluoromethylbenzaldehyde
CAS number: 477535-41-4

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
Eye contact:
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
No data
Boiling point:
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C8H4BrF3O
Molecular weight: 253.0

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen fluoride, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-溴-5-(三氟甲基)苯甲醛 在 三乙胺 、 pyridinium chlorochromate 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 4.5h， 生成 1-苯基-1-三甲基硅氧乙烯
  参考文献：
  名称：

  [EN] PESTICIDALLY ACTIVE DIAZINE-AMIDE COMPOUNDS
  [FR] COMPOSÉS DE DIAZINE-AMIDE À ACTION PESTICIDE

  摘要：

  式I（l）中的化合物，其中取代基如权利要求1中定义的那样，以及这些化合物的农药可接受的盐、立体异构体、对映异构体、互变异构体和N-氧化物，可用作杀虫剂。

  公开号：

  WO2020201079A1
• 作为产物：
  描述：

  3-溴-5-三氟甲基苯甲酸 在 草酰氯 、 二异丁基氢化铝 、 三乙胺 、 N,N-二甲基甲酰胺 作用下， 以 四氢呋喃 、 二氯甲烷 、 甲苯 为溶剂， 反应 1.83h， 生成 3-溴-5-(三氟甲基)苯甲醛
  参考文献：
  名称：

  [EN] NOVEL NEUROKININ 1 RECEPTOR ANTAGONIST COMPOUNDS
  [FR] NOUVEAUX COMPOSÉS ANTAGONISTES DU RÉCEPTEUR DE LA NEUROKININE 1

  摘要：

  本发明涉及一种根据公式（A）的化合物，其中n为1或2；R1和R2独立为氢，C1-4烷基，C1-4卤代烷基，C1-4烷氧基，CD3或卤素；R3为氢，C(=O)OR7或C1-4烷基，可选地被羟基或NR8R9取代；R4为氢或氧代；R5和R6独立为氢，羟基，NR8R9，C(=O)R7，C(=O)OR7，C(=O)NR8R9，C1-4烷基，其中所述C1-4烷基可选地被羟基，NR8R9或5-或6-成员的杂环环取代，其中所述5-或6-成员的杂环环可选地被C1-4烷基或C(=O)R7取代；或R5和R6与它们所连接的碳原子一起形成=CH2或5-或6-成员的杂环烷基，其中所述杂环烷基可选地被C1-4烷基取代；R7为氢或C1-4烷基；R8和R9独立为氢或C1-4烷基，或R8和R9与它们所连接的氮原子一起形成一个5-或6-成员的杂环环，或其药用可接受的盐或溶剂化物。本发明进一步涉及用于制备所述化合物的中间体，所述化合物用于治疗，包含所述化合物的药物组合物，使用所述化合物治疗或改善瘙痒性皮肤病或状况的方法，以及所述化合物在药物制造中的用途。

  公开号：

  WO2013124286A1
• 作为试剂：
  描述：

  3-溴-5-(三氟甲基)苄醇 、 3-氯-5-(三氟甲基)苯甲醛 在 3-溴-5-(三氟甲基)苯甲醛 作用下， 以to provide 3-bromo-5-(trifluoromethyl)benzaldehyde (22.03 g, 85%) as a pale yellow oil的产率得到3-溴-5-(三氟甲基)苯甲醛
  参考文献：
  名称：

  Derivatives of N-acyl-N′-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes

  摘要：

  本发明涉及一种化合物，其表示为式中每个符号如本说明书中所定义，该化合物具有优异的RBP4降低作用，并可作为药物组合物用于预防或治疗由RBP4增加介导的疾病或病状。

  公开号：

  US08853215B2

文献信息

• [EN] 3, 4 - SUBSTITUTED PIPERIDINE DERIVATIVES AS RENIN INHIBITORS<br/>[FR] DÉRIVÉS DE PIPÉRIDINE 3,4-SUBSTITUÉE CONVENANT COMME INHIBITEURS DE LA RÉNINE
  申请人：MERCK FROSST CANADA LTD

  公开号：WO2009140769A1

  公开（公告）日：2009-11-26

  The present invention relates to 3,4-substituted piperidinyl - based renin inhibitor compounds bearing at 4-position lsoqumolone and having the Formula (I) : The invention further relates to pharmaceutical compositions containing said compounds, as well as their use in treating cardiovascular events and renal insufficiency.

  本发明涉及具有4-位lsoqumolone的3,4-取代哌啶基肾素抑制剂化合物，其化学式为（I）：该发明还涉及含有上述化合物的药物组合物，以及它们在治疗心血管事件和肾功能不全中的用途。
• Highly efficient metal-free one-pot synthesis of <font>α</font>-aminophosphonates through reduction followed by Kabachnik–fields reaction using three-component system
  作者：Murali Krishna Kolli、Palani Elamathi、Govindasamy Chandrasekar、Vishweshwar Rao Katta、Gajendrasinh Balvantsinh Raolji

  DOI：10.1080/00397911.2017.1385083

  日期：2018.3.19

  ABSTRACT One-pot synthesis of α-aminophosphonates directly from aryl nitro compounds, aldehydes/ketones, and diethyl phosphite using sodium dithionite through reduction and followed by Kabachnik–Fields reaction under metal-free conditions is reported. The major advantages are excellent yield, high chemoselectivity, neutral reaction medium, and simple experimental procedure. This methodology consists

  摘要报道了使用连二亚硫酸钠通过还原，然后在无金属条件下进行 Kabachnik-Fields 反应，直接从芳基硝基化合物、醛/酮和亚磷酸二乙酯一锅法合成 α-氨基膦酸酯。主要优点是收率高、化学选择性高、反应介质中性、实验过程简单。该方法包括以下步骤：1) 硝基化合物形成胺，2) 胺和醛/酮形成亚胺，3) 磷酸盐加成到亚胺。图形概要
• DERIVATIVES OF N-ACYL-N'-PHENYLPIPERAZINE USEFUL (INTER ALIA) FOR THE PROPHYLAXIS OR TREATMENT OF DIABETES
  申请人：Kasai Shizuo

  公开号：US20120071489A1

  公开（公告）日：2012-03-22

  The present invention relates to a compound represented by the formula wherein each symbol is as defined in the present specification, which has a superior RBP4-lowering action and is useful as a pharmaceutical composition for the prophylaxis or treatment of a disease or condition mediated by an increase in RBP4.

  本发明涉及一种化合物，其化学式如下所示，其中每个符号如本说明书中所定义，该化合物具有优越的降低RBP4作用，并且可用作预防或治疗由RBP4增加介导的疾病或病况的药物组合物。
• [EN] PYRAZOLE MAGL INHIBITORS<br/>[FR] INHIBITEURS PYRAZOLE DE MAGL
  申请人：ABIDE THERAPEUTICS INC

  公开号：WO2018217805A1

  公开（公告）日：2018-11-29

  Provided herein are pyrazole compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful as modulators of monoacylglycerol lipase (MAGL). Furthermore, the subject compounds and compositions are useful for the treatment of pain.

  本文提供了吡唑化合物和包含该化合物的药物组合物。这些化合物和组合物可用作单酰基甘油酶（MAGL）的调节剂。此外，这些化合物和组合物可用于治疗疼痛。
• PIPERAZINE CARBAMATES AND METHODS OF MAKING AND USING SAME
  申请人：ABIDE THERAPEUTICS, INC.

  公开号：US20190202801A1

  公开（公告）日：2019-07-04

  Provided herein are piperazine carbamates and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful as modulators of MAGL and/or ABHD6. Furthermore, the subject compounds and compositions are useful for the treatment of pain.

  本文提供了哌嗪氨基甲酸酯和包含该化合物的药物组合物。所述化合物和组合物可用作MAGL和/或ABHD6的调节剂。此外，所述化合物和组合物可用于治疗疼痛。